ERBB2 and cancer: Other proteins that are dysregulated in cancer are also affected by AIMs, including: JNK [14]; JAK1 and STAT3 [15,16]; Her2 (ERBB2) [17]; death receptor 5 (TNFRSF10B) [18]; and cFLIP (CFLAR) [19].